The new psoriasis pathway: toward a unified theory of immunopathogenesis

References

• Nickoloff BJ, Wrone-Smith T. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am. J. Pathol.155(1), 145–158 (1999).
   PubMed Web of Science ®Google Scholar
• Nestle FO, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J. Clin. Invest.94(1), 202–209 (1994).
   PubMed Web of Science ®Google Scholar
• Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J. Am. Acad. Dermatol.46(1), 1–23 (2002).
   PubMed Web of Science ®Google Scholar
• Krueger GG, Langley RG, Leonardi C et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N. Engl. J. Med.356(6), 580–592 (2007).
   PubMed Web of Science ®Google Scholar
• Zhou X, Krueger JG, Kao MC et al. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol. Genomics13(1), 69–78 (2003).
   PubMed Web of Science ®Google Scholar
• Lew W, Bowcock AM, Krueger JG. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and “Type 1” inflammatory gene expression. Trends Immunol.25(6), 295–305 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang L, Badgwell DB, Bevers JJ 3rd et al. IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain. Mol. Cell. Biochem.288(1–2), 179–189 (2006).
   PubMed Web of Science ®Google Scholar
• Reddy J, Waldner H, Zhang X et al. Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J. Immunol.175(9), 5591–5595 (2005).
   PubMed Web of Science ®Google Scholar
• Mangan PR, Harrington LE, O’Quinn DB et al. Transforming growth factor-β induces development of the T(H)17 lineage. Nature441(7090), 231–234 (2006).
   PubMed Web of Science ®Google Scholar
• Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J. Clin. Invest.116(5), 1218–1222 (2006).
   PubMed Web of Science ®Google Scholar
• Lee E, Trepicchio WL, Oestreicher JL et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med.199(1), 125–130 (2004).
   PubMed Web of Science ®Google Scholar
• Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity22(3), 285–294 (2005).
   PubMed Web of Science ®Google Scholar
• Numasaki M, Fukushi J, Ono M et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood101(7), 2620–2627 (2003).
   PubMed Web of Science ®Google Scholar
• Komiyama Y, Nakae S, Matsuki T et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol.177(1), 566–573 (2006).
   PubMed Web of Science ®Google Scholar
• McAllister F, Henry A, Kreindler JL et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-α and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J. Immunol.175(1), 404–412 (2005).
   PubMed Web of Science ®Google Scholar
• Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol.6(11), 1123–1132 (2005).
   PubMed Web of Science ®Google Scholar
• Zheng Y, Danilenko DM, Valdez P et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature445(7128), 648–651 (2007).
   PubMed Web of Science ®Google Scholar
• Chan JR, Blumenschein W, Murphy E et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med.203(12), 2577–2587 (2006).
   PubMed Web of Science ®Google Scholar
• Piskin G, Sylva-Steenland RM, Bos JD, Teunissen MB. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J. Immunol.176(3), 1908–1915 (2006).
   PubMed Web of Science ®Google Scholar
• Cargill M, Schrodi SJ, Chang M et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet.80(2), 273–290 (2007).
   PubMed Web of Science ®Google Scholar
• Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science314(5804), 1461–1463 (2006).
   PubMed Web of Science ®Google Scholar
• Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol.174(6), 3695–3702 (2005).
   PubMed Web of Science ®Google Scholar
• Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity21(2), 241–254 (2004).
   PubMed Web of Science ®Google Scholar
• Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, Parks WC. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J. Cell Biol.137(6), 1445–1457 (1997).
   PubMed Web of Science ®Google Scholar
• Watson PH, Leygue ER, Murphy LC. Psoriasin (S100A7). Int. J. Biochem. Cell Biol.30(5), 567–571 (1998).
   PubMed Web of Science ®Google Scholar
• Broome AM, Ryan D, Eckert RL. S100 protein subcellular localization during epidermal differentiation and psoriasis. J. Histochem. Cytochem.51(5), 675–685 (2003).
   PubMed Web of Science ®Google Scholar
• Wolk K, Witte E, Wallace E et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol.36(5), 1309–1323 (2006).
   PubMed Web of Science ®Google Scholar
• Brand S, Beigel F, Olszak T et al. IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol.290(4), G827–G838 (2006).
   PubMed Web of Science ®Google Scholar
• Sano S, Chan KS, Carbajal S et al. STAT3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med.11(1), 43–49 (2005).
   PubMed Web of Science ®Google Scholar
• Caldenhoven E, van DT, Raaijmakers JA, Lammers JW, Koenderman L, de Groot RP. Activation of the STAT3/acute phase response factor transcription factor by interleukin-5. J. Biol. Chem.270(43), 25778–25784 (1995).
   PubMedGoogle Scholar
• Chen Z, Laurence A, Kanno Y et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl Acad. Sci. USA103(21), 8137–8142 (2006).
   PubMed Web of Science ®Google Scholar